ライフサイエンスコーパス: acuity

1 acuity (higher number indicates lower visual acuity).

2 ange expected from a 1-line change in visual acuity).

3 sensory systems without affecting perceptual acuity.

4 (V1) and disrupts the normal development of acuity.

5 d ON-OFF light responses and improved visual acuity.

6 hthalmic disease was associated with reduced acuity.

7 s significantly associated with lower visual acuity.

8 rogression of DME or DR and change in visual acuity.

9 T], phakic status, and best-corrected visual acuity.

10 citability, resulting in improved perceptual acuity.

11 etic Retinopathy Study best-corrected visual acuity.

12 transmission of light to the lens and visual acuity.

13 ates by providing high chromatic and spatial acuity.

14 information on visual function beyond visual acuity.

15 ease, even if asymptomatic with 20/20 visual acuity.

16 and vascularization and worse logMAR visual acuity.

17 ering from metamorphopsia and reduced visual acuity.

18 ent regimens, culture data, and final visual acuities.

19 nts (standardized mean differences of visual acuity 0.008, P = 0.890; and visual field loss, -0.019,

20 visual loss (mean [SD] best-corrected visual acuity, +0.95 [0.34] logMAR [20/180 Snellen]), childhood

21 (95% CI, -15.0 to 0.9) of those with visual acuity 20/40 or better initially, a clinically meaningfu

22 age, by 3 years), better preoperative visual acuity (22% vs. 32% with 0.4 logarithm of the minimum an

23 Best-corrected visual acuity after Descemet's stripping endothelial keratoplas

24 There was no difference in visual acuity, although more tIOL patients gained >/=1 line and

25 months after controlling for baseline visual acuity, although this finding was not statistically sign

26 Visual acuity, amblyopia, school performance, functioning, qual

27 To report differences in visual acuities among patients with Coats' disease who sought t

28 erto Rico, who presented with reduced visual acuity and bilateral diffuse, subretinal, confluent, pla

29 they suggest that the development of visual acuity and binocularity in mice involves different circu

30 id therapy, most patients show stable visual acuity and CCT, although ECD decreases.

31 Primary outcomes were change in visual acuity and change in central retinal thickness on optica

32 Evolution of visual acuity and clinical stage of BVMD correlated to OCT meas

33 c conditions in binocular uncorrected visual acuity and contrast sensitivity suggest low pupillary de

34 exhibited functional deficiencies in visual acuity and contrast sensitivity, whereas diabetic REDD1-

35 correlation was found between logMAR visual acuity and FAZ area in both the superficial (rho = 0.29;

36 f the sensory space plays a critical role in acuity and fine discrimination during somesthesis.

37 The data from this study suggest that visual acuity and foveal structure in patients with RP are pres

38 nes and rods, suffer severely reduced visual acuity and impaired color vision.

39 , with summation strategies, which sacrifice acuity and leave images blurry and slow [3].

40 Cases with normal visual acuity and mild glaucoma had significantly higher scores

41 ts with CPR-type diplopia have better visual acuity and more metamorphopsia than those without CPR-ty

42 retinal/sub-RPE hemorrhage and poorer visual acuity and of SNPs at the CFH locus with drusen area may

43 r environmental factors, compromising visual acuity and often resulting in blindness.

44 ophthalmic characteristics, including visual acuity and retinal thickness, and medical history charac

45 Visual acuity and RNFL thickness also showed greater diminution

46 ore and after training, wrist position sense acuity and spatial movement accuracy in an untrained, di

47 nd FIL618 provided better uncorrected visual acuity and spectacles independence for intermediate/clos

48 Worse initial visual acuity and visual fields were associated with lower init

49 Visual acuity and visual thresholds; total nuclear layer, inner

50 ted outcomes (symptoms, cosmesis) and visual acuity, and evaluate effects of surgical variations.

51 outcomes of survival, local control, visual acuity, and eye retention in patients treated with repea

52 lialization, best spectacle-corrected visual acuity, and infiltrate or scar size at 3 months.

53 history, family history of glaucoma, visual acuity, and intraocular pressure measurements using the

54 l acuity (CDVA), uncorrected distance visual acuity, and minimum corneal thickness were assessed.

55 They presented with a 20/20 distance visual acuity, and Parinaud 1,5 near visual acuity in both eyes

56 nonpersistent loss of best-corrected visual acuity, and transient hypotony (requiring no surgical in

57 ing from night blindness to decreased visual acuity, and were diagnosed between the ages of 1 and 11

58 Detailed history, visual acuity, anterior segment and posterior segment examinati

59 e demonstrate that dressmakers' stereoscopic acuities are better than those of non-dressmakers, for b

60 isms driving the development of retinal high-acuity areas (HAAs).

61 ot a correlation between preoperative visual acuity as a predictor of final postoperative visual acui

62 (improved) (Snellen equivalent 20/40) visual acuity at 3 months after controlling for baseline visual

63 cohort members with complete data on visual acuity at age 15 or 16 years, measured in 1961, 1974, an

64 al photocoagulation (PRP), as well as visual acuity at baseline and at 1 year.

65 s and compare choroidal thickness and visual acuity at each time point.

66 Best-corrected visual acuity at fluid resolution was not statistically differe

67 er surgery; 5 of these 7 eyes had NLP visual acuity at the most recent examination.

68 Three-month mean (+/- standard deviation) acuity: AT Lisa, binocular uncorrected distance visual a

69 diseases and best-corrected distance visual acuity (BCDVAbetter-eye) of 20/50 to 20/200.

70 , had wet AMD, and had best-corrected visual acuity (BCVA) 10/200 to 20/80 in the study eye and 20/20

71 Best-corrected visual acuity (BCVA) 6 months after surgery.

72 e relationship between best-corrected visual acuity (BCVA) and central retinal thickness (CRT) in eye

73 Best corrected visual acuity (BCVA) and stereoacuity (Stereo Randot graded cir

74 he primary outcome was best-corrected visual acuity (BCVA) at 6 months follow-up.

75 ed alpha level 0.1) in best-corrected visual acuity (BCVA) change from baseline of brolucizumab versu

76 he patients (%) with a best-corrected visual acuity (BCVA) improvement of >/=15 letters from preopera

77 Mean best-corrected visual acuity (BCVA) letter score change, proportion of patient

78 The mean preoperative best-corrected visual acuity (BCVA) was 1.39+/-0.64 logarithm of the minimum a

79 ion (logMAR) (Snellen) best-corrected visual acuity (BCVA) was 1.81+/-0.56 (20/1290).

80 Median best-corrected visual acuity (BCVA) was 20/30 at presentation (IQR, 0.00-0.50)

81 preoperative and final best-corrected visual acuity (BCVA) was assessed and the outcomes are reported

82 Best-corrected visual acuity (BCVA) was compared between late AMD subtypes; ge

83 n change from baseline best-corrected visual acuity (BCVA) was determined at week 12, after which gro

84 Best-corrected visual acuity (BCVA) was measured 30 to 90 days preoperatively

85 e tomography (SD-OCT), best-corrected visual acuity (BCVA), and microperimetry.

86 Best corrected visual acuity (BCVA), central retinal thickness (CRT) and conco

87 res were postoperative best-corrected visual acuity (BCVA), endothelial cell density (ECD), and compl

88 c stages and underwent best-corrected visual acuity (BCVA), fundus autofluorescence and spectral doma

89 optic neuropathy, and best-corrected visual acuity (BCVA).

90 lar surface stability, best-corrected visual acuity (BCVA).

91 device retention, and best-corrected visual acuity (BCVA).

92 nd the visual outcome (best corrected visual acuity (BCVA); logMAR), as follows: before treatment (at

93 We recorded Snellen visual acuity before and after intervention, as well as the amp

94 enhancement, the uncorrected distance visual acuity before enhancement ranged from 20/80 to 20/25, an

95 Visual acuities better than 0.2 LogMAR were maintained between

96 easures were best spectacle-corrected visual acuity (BSCVA) with astigmatism (cylinder) and spherical

97 ssed 3-month best spectacle-corrected visual acuity (BSCVA), 3-month infiltrate/scar size, corneal pe

98 t rejection, best spectacle-corrected visual acuity (BSCVA), central corneal thickness (CCT), endothe

99 ers included best spectacle corrected visual acuity (BSCVA), central corneal thickness (CCT), endothe

100 on obtained; best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), and topogra

101 kle cell disease exhibiting preserved visual acuity but showing temporal macular retinal atrophy were

102 al processing are thought to enhance spatial acuity by combining matched input from the two eyes.

103 hrough two eyes is thought to improve visual acuity by enhancing sensitivity to fine edges.

104 /- 0.06; monocular distance corrected visual acuity (CDVA), 0.02 logMAR +/- 0.06; binocular uncorrect

105 ine to 6 months in corrected distance visual acuity (CDVA), uncorrected distance visual acuity, and m

106 complications and corrected distance visual acuity (CDVA).

107 come measures were corrected distance visual acuity (CDVA, logarithm of the minimum angle of resoluti

108 ploration; however, touch also recruits high-acuity central representation within early visual areas

109 Other outcomes included visual acuity, central subfield retinal thickness, and number o

110 Best-corrected visual acuity changed by -0.2 letters in the YAG laser group an

111 acuity in uveitic eyes (5 letters = 1 visual acuity chart line; potential range of change in letters

112 Visual acuity, clinical course, and multimodal imaging study re

113 Visual acuity correlated with foveal avascular zone area and pa

114 ncluded cover testing, best corrected visual acuity, cycloplegic objective refraction, slit lamp as w

115 ocular pressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane

116 provide Snellen equivalents whenever visual acuity data are reported in a non-Snellen format to impr

117 acuity (UCVA) and distance-corrected visual acuity (DCVA) in 4 m, 80 cm, 60 cm, and 40 cm slit-lamp

118 t onset, visual acuity survival time, visual acuity decline rate, and electroretinography and imaging

119 ajority of patients but despite this, visual acuities did not deteriorate significantly over the stud

120 Visual acuity did not decrease significantly after the tear, bu

121 Because best-corrected visual acuity does not correspond directly to GA lesion enlarge

122 The visual acuity during last follow-up was 20/231 (range, light pe

123 ons: best-corrected distance and near visual acuity evaluation; dilated fundus examination; OCT with

124 Improvements in visual acuity for the three working distances were statisticall

125 atients maintain better than expected visual acuity for years.

126 nge in mean and median best-corrected visual acuity from baseline at years 1 and 2.

127 neural network for the estimation of visual acuity from optical coherence tomography (OCT) images of

128 significant improvement of 1 line of Snellen acuity (from 6/9 bilaterally to 6/6 on the left and 6/5-

129 IDH3A variants, age at diagnosis, visual acuity, fundus appearance, visual field, and full-field

130 , demonstrating a mean best-corrected visual acuity gain of 8.3 letters (mean 68.8 +/- 11) at month 1

131 Best-corrected visual acuity gains achieved during VISTA DME were maintained a

132 Visual acuity had improved in early tears before the tear (+5.6

133 chorioretinal lesions had healed and visual acuity had improved to 20/25 OD and 20/20 OS.

134 the onset of symptoms, the patient's visual acuity had improved to 20/60 OD and 20/25 OS, with intra

135 navigated patients on age, race, sex, cancer acuity (high vs low), comorbidity score, and preenrollme

136 ding speed, critical print size, and reading acuity (higher number indicates lower visual acuity).

137 levance of these findings relative to visual acuity, however, remains largely unknown at this time.

138 Most patients had relatively good acuity; however, advanced ophthalmic disease was associa

139 eappearance of the ellipsoid line and visual acuity improved from 20/100 before surgery to 20/25, 10

140 Visual acuity improved in almost all eyes that underwent surger

141 Uncorrected distance visual acuity improved substantially in all eyes (from mean 20/

142 Visual acuity improved when IZ was restored.

143 ass of anesthesia conferred a greater visual acuity improvement (p=0.06).

144 visual acuity, and Parinaud 1,5 near visual acuity in both eyes.

145 evalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in Europe

146 were important determinants of final visual acuity in eyes with the cuticular drusen phenotype (both

147 Visual acuity in LE was no light perception.

148 ; monocular and binocular uncorrected visual acuity in photopic and mesopic conditions, for far (4 m)

149 Mean binocular uncorrected visual acuity in photopic conditions was 0.03 LogMAR for far, 0

150 safe and effective means of improving visual acuity in RP patients and that it does not seem to be as

151 Visual acuity in the best eye decreases to below 0.5 in 4.3 yea

152 s, adjusting for age, sex, presenting visual acuity in the better-seeing eye, educational level, inco

153 ot have lenses fitted because of good visual acuity in the other eye or a contraindication for lens w

154 hange from baseline in best-corrected visual acuity in uveitic eyes (5 letters = 1 visual acuity char

155 rates, which did not affect the final visual acuity, in the standard CL group.

156 tive and postoperative best-corrected visual acuity, incidence of macular edema, posterior capsular o

157 ere included in the meta- analysis of visual acuity, including 9 retrospective reports and one random

158 Best-corrected visual acuity, Indian Vision Function Questionnaire (IND-VFQ),

159 eal injections of a specific drug and visual acuity interval.

160 to provide a Snellen equivalent when visual acuity is not in a Snellen format.

161 lder age, hypercholesterolemia, worse visual acuity, larger choroidal neovascularization (CNV) area,

162 dren with vision impairment (recorded visual acuity less than 6/18 for distance in the better eye) wa

163 in those cases with better presenting visual acuities, lesser foveal thicknesses, and no associated P

164 onship between NEI VFQ-25 scores with visual acuity letter score (VALS) and central retinal thickness

165 Best-corrected visual acuity letter score gain of 15 letters or more was more

166 size was smaller than a spatial resolution (acuity) limit that was independent of reading skill.

167 tter visual outcomes (12-month median visual acuity, logarithm of the minimum angle of resolution [lo

168 Median BCVA (best-corrected visual acuity, logMAR) was 0.1 in the MFS group versus 0.3 in n

169 fied criteria of at least a 10-letter visual acuity loss at 2 consecutive visits or at least a 15-let

170 cutive visits or at least a 15-letter visual acuity loss from the best previous measurement at 1 visi

171 sensitivity during fast flight, but limiting acuity loss when the fly is still.

172 The optimal strategy would manifest as acuity loss, specifically in regions of fast motion, and

173 t the development of binocularity and visual acuity may engage distinct circuits in the mouse visual

174 except 1 maintained or improved their visual acuity (mean [SD], +3.8 [9.6] letters).

175 PR-type diplopia had better worse-eye visual acuity (mean difference, -0.23; 95% CI, -0.37 to -0.09 l

176 participants underwent best-corrected visual acuity measurement, fundus examination, and spectral-dom

177 rmat to improve ease of understanding visual acuity measurements.

178 vitreal corticosteroids and had final visual acuities of 20/40, 20/70, and hand movements.

179 better eye) and blindness (presenting visual acuity of <3/60 in the better eye) by cause, age, region

180 ion impairment (defined as presenting visual acuity of <6/18 but >/=3/60 in the better eye) and blind

181 8%, 46 of 48 eyes) had a preoperative visual acuity of 20/200 or worse.

182 ositive filamentous fungal ulcers and visual acuity of 20/40 to 20/400 reexamined 6 days after initia

183 Participants had a baseline visual acuity of 20/400 or worse and were randomized to receive

184 der with, in each eye, best corrected visual acuity of 20/60 or worse, or visual field less than 20 d

185 14.7) years, mean (SD) best-corrected visual acuity of all eyes was 47.8 (16.9) Early Treatment Diabe

186 (<6 dB) but very good best-corrected visual acuity of at least 72 Early Treatment Diabetic Retinopat

187 applied this network to model the impact on acuity of defined OCT changes in subretinal fluid, subre

188 After controlling for comorbidity and acuity of illness, radiocontrast administration associat

189 ssion model, controlling for comorbidity and acuity of illness, to estimate the risk of AKI associate

190 ears who underwent screening, 694 had visual acuity of less than 6/9 in both eyes, and 535 underwent

191 benefit of CABG over PCI no longer varied by acuity of presentation, with a hazard ratio for MACCE in

192 Animals employ active touch to optimize the acuity of their tactile sensors.

193 e three patients, the last documented visual acuity on the Snellen eye chart before the injection ran

194 ophthalmologic examination, including visual acuity, optical coherence tomography B-scan, and OCTA.

195 2 patients and persistent severe low visual acuity or blindness for 5 patients.

196 eral uveitis (OR 3.51, P = .009), low visual acuity (OR 5.1, P = .001), high laser-flare (LF) values

197 as a predictor of final postoperative visual acuity outcome (r=-0.32; P = 0.09; 95% confidence interv

198 D usage had no effect on the ultimate visual acuity outcome.

199 Visual acuity outcomes did not differ between apex LD and HD gr

200 Visual acuity outcomes favored the E10030 1.5 mg combination th

201 relationship and to positively impact visual acuity outcomes in ophthalmic diseases.

202 nd no association between TZD use and visual acuity outcomes or DME progression, and no consistent ev

203 Visual acuity outcomes were determined for each early response

204 presenting clinical features, visual acuity outcomes, and antibiotic susceptibility patterns.

205 To investigate refractive and visual acuity outcomes, patient satisfaction, and spectacle ind

206 Visual acuity outcomes, postoperative complications, and device

207 ness of some treatments for improving visual acuity outcomes.

208 a 3- to 5-letter improvement in mean visual acuity over the 3 months after the switching rules were

209 ndardized eye examinations, including visual acuity, perimetry, slit-lamp examination, intraocular pr

210 Best-corrected postoperative visual acuity, postoperative complications of the reported tech

211 Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse

212 Decreased visual acuity preceded conversion by up to 2 months and then de

213 Visual acuity progressively declined from stage 1 through stage

214 Presenting visual acuities ranged from 20/25 to hand motion.

215 cluding microperimetry, low-luminance visual acuity, reading speed assessments, and patient-reported

216 Similarly, visual acuity recovers or improves within 1 month of the proced

217 ASIK surgery), and clinical measures (visual acuity, refractive error, and slitlamp and posterior seg

218 Visual acuity remained unchanged following revision.

219 rs to provide Snellen equivalents for visual acuity reported in non-Snellen formats.

220 mber 14, 2016, one reviewer evaluated visual acuity reporting among all articles published in 4 ophth

221 onal distance, intermediate, and near visual acuity, resulting in high levels of both spectacle indep

222 Ten-year rates of visual acuity retention were 8.7% (95% CI, 4.1%-15.6%) for at l

223 diversity provides a new logic for enhanced-acuity retinal prosthetics.

224 re was the change in the preoperative visual acuity score at postoperative month 1 and at the last no

225 eration and a baseline best-corrected visual acuity score of 20/100 or less in the study eye were enr

226 eeded to validate and calibrate our portable acuity screening tools so amblyopia could be detected qu

227 3 symptomatic subjects, 2 had reduced visual acuity secondary to nonorganic visual loss and bilateral

228 One patient developed decreased visual acuity secondary to radiation retinopathy.

229 Visual acuity, size of RCH, and degree of exudation were record

230 Visual acuity, size of RCH, and degree of exudation.

231 edical history review, best-corrected visual acuity, slitlamp biomicroscopy, intraocular pressure mea

232 To analyze the long-term visual acuity, strabismus, and nystagmus outcomes in Group D re

233 Visual acuity survival analyses indicate that the optimal inter

234 Age at onset, visual acuity survival time, visual acuity decline rate, and el

235 To maximize visual acuity, the fovea should only contain photoreceptors con

236 reciprocal detriment in patients with lower acuity; this was in part a result of more favorable dono

237 locations from peripheral grating resolution acuity thresholds.

238 ema with a significant improvement in visual acuity to 20/20.

239 work demonstrated the relationship of visual acuity to specific, programmed changes in OCT characteri

240 cted and spectacle corrected distance visual acuity (UCDVA/CDVA), automated kerato-refractometry (Top

241 ding manifest refraction; uncorrected visual acuity (UCVA) and distance-corrected visual acuity (DCVA

242 0.1 logMAR; mean uncorrected distance visual acuity (UDVA) also improved significantly from 0.90 +/-

243 Lisa, binocular uncorrected distance visual acuity (UDVA), -0.01 logMAR +/- 0.06; monocular distance

244 8; binocular uncorrected intermediate visual acuity (UIVA) at 80 cm, -0.05 logMAR +/- 0.14; postopera

245 +/- 0.06; binocular uncorrected near visual acuity (UNVA) at 40 cm, 0.05 logMAR +/- 0.08; binocular

246 ical activity, and variability in perceptual acuity, using human somatosensory cortex as a model.

247 AMD participants had better-eye visual acuity (VA) <20/32 and >20/100, while controls had binoc

248 study eyes from 305 adults with PDR, visual acuity (VA) 20/320 or better, and no history of PRP.

249 Change in visual acuity (VA) and occurrence of intraoperative and postope

250 A 12-month phase 3b visual acuity (VA) assessor-masked, multicenter, randomized, in

251 ME) is the leading cause of decreased visual acuity (VA) associated with retinal vein occlusion (RVO)

252 defocus curve showed peaks with best visual acuity (VA) at 0.00 D (-0.07 logMAR) and -2.00 D (-0.02

253 een use of thiazolidinediones (TZDs), visual acuity (VA) change, and diabetic eye disease incidence a

254 d maximum GA area allowing sufficient visual acuity (VA) for daily tasks.

255 ctive observational studies reporting visual acuity (VA) in non-treated patients, 24 studies in total

256 In the HSK group, the level of visual acuity (VA) in the affected eye had the greatest impact

257 have demonstrated that the better the visual acuity (VA) is at the time of treatment initiation, the

258 he primary outcome was mean change in visual acuity (VA) letter score (VALS) from the randomization v

259 Data including age, sex, visual acuity (VA) measured on Early Treatment Diabetic Retinop

260 sceptibility profiles, treatment, and visual acuity (VA) outcomes of endophthalmitis caused by Coryne

261 without laser using an individualized visual acuity (VA) stabilization criteria in patients with visu

262 Visual acuity (VA) was measured during their encounter or obtai

263 Risk factors for final visual acuity (VA) were analyzed, and rate of strabismus and ny

264 asures included surgical feasibility, visual acuity (VA), and complications.

265 rral approach and assesses presenting visual acuity (VA), best-corrected VA, digital fundus imaging,

266 surgery, level of patient discomfort, visual acuity (VA), surgically induced refractive change (SIRC)

267 a comprehensive clinical examination, visual acuity (VA), visual fields, electroretinography, color v

268 , lens and retinal abnormalities, and visual acuity (VA).

269 smoothing curves were used to display visual acuity (VA).

270 -field electroretinogram (ffERG), and visual acuity (VA).

271 s associated with less improvement in visual acuity (VA).

272 raphy (SD OCT) and the correlation to visual acuity (VA).

273 minimum angle of resolution [logMAR] visual acuity [VA]) were evaluated in the 81 patients in this g

274 oped is able to generate an estimated visual acuity value from OCT images in a population of patients

275 Mesopic binocular uncorrected visual acuity values were similar to photopic values.

276 nt control of attentional resources and high-acuity vision are both fundamental for survival.

277 Comparison was made of visual acuity, visual field height, global RNFL thickness, and

278 nclude IOP, glaucoma medical therapy, visual acuity, visual fields, and surgical complications.

279 Visual acuity was 0.18 logarithm of the minimum angle of resolu

280 Visual acuity was 0.4 and 0.07 after 5 years in the better-seei

281 Visual acuity was 20/20 OU, and color vision was normal in both

282 Initial visual acuity was associated with the prognosis.

283 Visual acuity was blind (VA >20/400) in 38.5% of eyes with uvei

284 Asymmetry in visual acuity was found in 31% of patients.

285 Presenting visual acuity was generally poor (20/50 to >20/200 in 27%; 20/2

286 Best-corrected visual acuity was improved in 13 eyes (81.25%), remained stable

287 Best-corrected visual acuity was measured using the Early Treatment Diabetic R

288 Uniocular presenting distance visual acuity was measured using the logMAR chart.

289 s of topical corticosteroid treatment visual acuity was worsening with similar optical coherence tomo

290 Only 1 outcome (visual acuity) was consistently reported in greater than half t

291 Mean preoperative and postoperative visual acuities were similar (20/60 vs. 20/80, respectively).

292 iduals in the implant group with poor visual acuity were able to overcome their initial deficits by t

293 OP, mean glaucoma medication use, and visual acuity were compared.

294 >/=15-letter gains in best-corrected visual acuity were observed in 34.5% (10/29) and 24.1% (7/29) o

295 dards of utility for a given level of visual acuity were used to derive costs and quality-adjusted li

296 rehensive assessment of visual function than acuity, which only determines the smallest resolvable pa

297 ch can result in an overestimation of neural acuity with existing one-dimensional neural information

298 ELM is intact, there is a shallow decline in acuity with increasing subretinal fluid but a much steep

299 Using habitual distance visual acuity (with correction if prescribed), participants wer

300 plant group, individuals with initial visual acuity worse than 20/40 showed additional improvement in